Mariola Dymkowska

Mariola Dymkowska is a seasoned Drug Development and Medical Affairs Professional with extensive experience in clinical development, pharmacovigilance, and medical affairs, particularly in hematology-oncology, oncology, and rare diseases. Since February 2007, Mariola has been with VERTO MD, and has held various global clinical development roles with companies including Molecular Partners, Debiopharm International SA, Aurealis Therapeutics, Cantargia AB, MorphoSys, argenx, Cellestia Biotech, Strongbridge Biopharma plc, and Takeda. Mariola's expertise spans early clinical development and First in Human studies, focusing on Antibody Drug Conjugates, immunology-oncology, and orphan diseases. Educational credentials include an MD from the Medical University of Warsaw, obtained between 1981 and 1987.